Vanguard Group’s Estrella Immunopharma ESLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$242K	Buy	282,843 +5,265	+2%	+$4.51K	﹤0.01%	4058
2025 Q1	$257K	Buy	277,578 +255,894	+1,180%	+$237K	﹤0.01%	4021
2024 Q4	$24.5K	Hold	21,684	–	–	﹤0.01%	4250
2024 Q3	$25.2K	Buy	+21,684	New	+$25.2K	﹤0.01%	4289